six
monoclon
antibodi
rais
felin
caliciviru
fcv
strain
use
enzymelink
immunoflowassay
elifa
analys
isol
fcv
forti
seven
field
isol
obtain
cat
acut
oralrespiratori
diseas
chronic
oral
lesion
cat
show
vaccin
reaction
ie
clinic
sign
fcv
infect
shortli
vaccin
eight
refer
strain
includ
three
vaccin
strain
base
also
examin
strain
deriv
variou
sourc
react
six
monoclon
antibodi
wherea
field
isol
react
gener
field
isol
show
spectrum
reactiv
select
isol
could
distinguish
howev
clear
cut
differ
clinic
group
overal
oralrespiratori
group
show
less
reactiv
monoclon
suggest
less
relat
although
group
appear
close
relat
none
isol
test
react
six
monoclon
antibodi
felin
caliciviru
fcv
member
famili
calicivirida
import
caus
acut
oral
respiratori
diseas
cat
gaskel
dawson
fcv
also
caus
acut
febril
lame
syndrom
pedersen
et
al
bennett
et
al
dawson
et
al
viru
also
found
associ
chronic
oral
lesion
cat
thompson
et
al
knowl
et
al
tenorio
et
al
fcv
vaccin
avail
time
reason
effect
protect
diseas
infect
avail
vaccin
modifi
live
product
administ
subcutan
vaccin
reaction
ie
clinic
sign
fcv
infect
occur
shortli
vaccin
report
dawson
et
al
viru
isol
case
differenti
vaccin
field
virus
difficult
mani
strain
fcv
isol
vari
slightli
term
pathogen
antigen
povey
hale
kahn
et
al
dawson
et
al
convent
cross
viru
neutralis
vn
test
differ
isol
demonstr
isol
reason
close
relat
constitut
one
serotyp
povey
kalunda
et
al
monoclon
antibodi
analysi
also
appli
fcv
isol
shown
antigen
variat
also
presenc
least
seven
neutralis
epitop
tohya
et
al
tohya
et
al
howev
work
take
account
clinic
origin
isol
test
recent
work
use
convent
viru
neutralis
test
found
differ
fcv
isol
accord
clinic
origin
dawson
et
al
aim
studi
determin
whether
monoclon
antibodi
would
also
reveal
differ
perhap
aid
futur
type
sytem
includ
differenti
vaccin
field
virus
fifti
five
isol
analys
compris
isol
obtain
cat
acut
oralrespiratori
diseas
isol
cat
chronic
oral
lesion
isol
cat
vaccin
reaction
associ
use
vaccin
cat
vaccin
reaction
associ
use
vaccin
b
see
dawson
et
al
full
descript
criteria
use
segreg
isol
group
vaccin
viru
strain
vaccin
viru
b
strain
vaccin
viru
n
strain
refer
virus
also
includ
tabl
field
virus
isol
oropharyng
swab
use
two
three
cell
cultur
passag
felin
embryoderiv
fe
cell
dawson
et
al
vaccin
viru
suppli
manufactur
passag
two
three
time
fe
cell
use
refer
strain
unknown
high
passag
six
mous
monoclon
antibodi
prepar
fcv
strain
deriv
commerci
vaccin
vaccin
n
carter
use
six
monoclon
antibodi
found
react
specif
infect
cell
indirect
immunofluoresc
specif
major
capsid
protein
fcv
strain
immunoprecipit
unpublish
data
howev
three
six
monoclon
antibodi
react
strain
sodium
dodecyl
sulphatepolyacrylamid
gel
electrophoresi
sdspage
western
blot
dawson
suggest
monoclon
antibodi
may
bind
linear
epitop
major
capsid
protein
wherea
bind
other
may
conform
depend
suggest
shin
et
al
dawson
also
demonstr
three
monoclon
antibodi
possess
abil
neutralis
vaccin
n
viru
vitro
monoclon
antibodi
isotyp
except
iggl
polyclon
antiserum
fcv
strain
produc
specificpathogenfre
cat
dawson
et
al
virus
grown
felin
embryoderiv
cell
harvest
freezethaw
three
time
clarifi
lowspe
centrifug
clarifi
prepar
mix
equal
volum
phosphatebuff
salin
pb
ool
vv
tween
pass
filter
aliquot
store
use
singl
batch
antigen
use
test
format
enzymelink
immunoflowassay
elifa
use
pierc
warrin
uk
briefli
monoclon
antibodi
immobilis
nitrocellulos
bittl
et
al
carter
dawson
et
al
dawson
et
al
dawson
et
al
dawson
et
al
povey
et
al
omerod
jarrett
povey
povey
high
passag
laboratori
strain
b
modifi
live
vaccin
base
strain
modifi
live
vaccin
base
strain
membran
format
use
captur
variou
fcv
isol
antigen
whilst
unbound
materi
includ
unreact
fcv
antigen
pass
posit
bind
fcv
isol
variou
monoclon
antibodi
detect
use
polyclon
antifcv
serum
follow
monoclon
anticat
iggbiotin
sigma
extravidinperoxidas
conjug
sigma
tetramethylbenzidin
tmb
pgml
acet
buffer
ph
hydrogen
peroxid
chromogen
substrat
pass
membran
produc
colour
reaction
substrat
collect
elisa
plate
sulphur
acid
ad
well
optic
densiti
od
well
determin
nm
reagent
concentr
volum
flow
rate
optimis
accord
manufactur
instruct
tabl
test
contain
refer
posit
vaccin
n
deriv
strain
neg
uninfect
cell
cultur
antigen
control
isol
also
test
test
fcv
monoclon
antibodi
irrelev
antifelin
coronaviru
monoclon
antibodi
test
carri
triplic
well
repeat
least
two
occas
result
consid
posit
mean
od
triplic
test
well
produc
relev
antifcv
monoclon
antibodi
least
od
greater
irrelev
monoclon
antibodi
od
three
triplic
well
isol
test
fell
outsid
mean
three
test
result
reject
test
repeat
elifa
test
sampl
gave
neg
result
monoclon
antibodi
use
sampl
analys
sdspage
western
blot
polyclon
sera
confirm
total
reactiv
monoclon
antibodi
isol
b
monoclon
antibodi
use
group
g
presenc
fcvspecif
antigen
sampl
use
criteria
repeat
mean
test
standard
deviat
result
refer
posit
control
vaccin
n
deriv
strain
monoclon
antibodi
k
k
f
respect
monoclon
antibodi
react
vaccin
strain
rais
also
react
refer
strain
vaccin
strain
also
base
tabl
howev
none
remain
refer
clinic
isol
react
monoclon
test
possibl
except
isol
g
vaccin
reaction
group
tabl
gener
vari
pattern
reactiv
monoclon
cross
reactiv
amongst
clinic
isol
test
total
clinic
isol
test
least
tabl
ten
clinic
isol
test
react
monoclon
antibodi
use
tabl
spectrum
monoclon
antibodi
bind
pattern
observ
within
clinic
group
select
isol
could
distinguish
tabl
howev
consist
differ
overal
bind
pattern
clinic
group
oralrespiratori
diseas
group
contain
higher
proport
isol
react
monoclon
antibodi
tabl
reflect
lower
reactiv
acut
oralrespiratori
diseas
isol
overal
compar
clinic
group
tabl
contrast
isol
vaccin
b
reaction
react
least
one
monoclon
purpos
studi
determin
monoclon
antibodi
could
use
type
isol
felin
caliciviru
enabl
separ
isol
accord
clinic
origin
convent
polyclon
vn
analys
shown
felin
calicivirus
close
relat
constitut
one
serotyp
although
spectrum
antigen
differ
seen
within
povey
kalunda
et
al
similar
find
demonstr
studi
use
monoclon
antibodi
although
direct
comparison
studi
possibl
sinc
rang
differ
isol
antibodi
use
tohya
et
al
tohya
et
al
littl
work
done
howev
attempt
correl
antigen
differ
clinic
origin
isol
previou
work
shown
differ
four
clinic
group
test
use
select
polyclon
antisera
vn
test
dawson
et
al
thu
attempt
use
focus
approach
monoclon
antibodi
analysi
show
differ
clearli
howev
although
studi
abl
distinguish
select
strain
clear
cut
differ
clinic
group
seen
would
suggest
epitop
analys
monoclon
antibodi
indic
fcv
clinic
origin
might
possibl
monoclon
antibodi
deriv
either
epitop
within
fcv
strain
would
enabl
better
separ
also
comparison
polyclon
vn
analysi
fcv
isol
monoclon
antibodi
bind
pattern
may
necessarili
yield
similar
result
tohya
et
al
shown
least
seven
neutralis
epitop
present
fcv
major
capsid
protein
complex
interplay
epitop
may
repres
monoclon
antibodi
use
studi
may
produc
separ
seen
dawson
et
al
although
monoclon
antibodi
bind
pattern
distinct
enough
group
isol
higher
proport
isol
cat
acut
oralrespiratori
diseas
group
react
monoclon
antibodi
use
suggest
less
relat
howev
number
isol
group
rel
small
group
may
well
overlap
origin
isol
obtain
appar
vaccin
reaction
unclear
previou
studi
use
vn
test
isol
vaccin
b
reaction
appear
similar
parent
vaccin
b
suggest
isol
may
origin
vaccin
dawson
et
al
contrast
vaccin
reaction
isol
look
differ
parent
vaccin
appear
like
field
virus
howev
present
studi
use
monoclon
antibodi
differ
group
seen
except
possibl
isol
none
isol
appear
ident
parent
vaccin
sever
possibl
reason
firstli
appar
vaccin
reaction
isol
may
fact
field
virus
may
origin
vaccin
altern
may
deriv
vaccin
viru
alter
passag
cat
howev
limit
work
serial
reisol
made
day
experiment
infect
cat
shown
loss
reactiv
panel
monoclon
antibodi
shortterm
passag
cat
unpublish
data
greater
select
pressur
may
howev
oper
field
also
possibl
viru
may
alter
cell
cultur
reisol
passag
howev
strain
use
studi
appear
stabl
vitro
differ
cell
cultur
passag
histori
yet
still
retain
abil
bind
monoclon
antibodi
two
monoclon
antibodi
use
studi
previous
map
amino
acid
sequenc
variabl
region
centr
capsid
protein
milton
et
al
present
studi
two
monoclon
antibodi
react
similarli
isol
support
suggest
milton
et
al
bind
differ
epitop
within
sequenc
